RecruitingNot ApplicableNCT03462329

Patient's Pretreatment Expectations About Post-Lyme Symptoms

Impact of Patient's Pretreatment Expectations on Treatment Outcome of Early Lyme Borreliosis


Sponsor

University Medical Centre Ljubljana

Enrollment

200 participants

Start Date

Jun 1, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators will focus on pretreatment expectations of patients with early Lyme disease manifested as erythema migrans with the aim of assessing the association between pretreatment expectations quantified with a questionnaire and treatment outcome quantified with the presence of post-Lyme symptoms. Furthermore, the investigators will compare the prevalence of nonspecific symptoms among patients and among age-matched controls without a history of Lyme borreliosis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Antibiotics (preferentially oral doxycycline 100 mg bid) for people with erythema migrans. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAntibiotics (preferentially oral doxycycline 100 mg bid)

Patients will be treated with antibiotics for Lyme disease.


Locations(1)

University Medical center Ljubljana

Ljubljana, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03462329


Related Trials